氟伐他汀辅助治疗早期糖尿病肾病的疗效观察及对氧化应激的影响(3)
[2] 王海燕. 肾脏病学[M]. 2版. 北京: 人民卫生出版社, 1998: 956.
[3] Amaud C, Mach F. Pleiotropic effects of statins in atherosclerosis:role on endothelial fimction, inflammation and immunomodulation[J]. Arch Mal Coeur Vaiss, 2005, 98(6): 661-666.
[4] 丁晓洁. 不同剂量氟伐他汀对血脂正常的早期糖尿病肾病的影响[J]. 安徽医药, 2014, 18(4): 740-741.
[5] 郑美玲, 樊均明. 氧化应激对糖尿病肾病时细胞、细胞外基质及血管通透性的影响机制[J]. 中国组织工程研究与临床康复, 2007, 11(25): 4988-4991.
[6] 刘东宁, 朱新宁, 寇华炜, 等. 氟伐他汀对糖尿病大鼠心肌组织氧化应激反应的影响[J]. 宁夏医学杂志, 2010,32(12): 1107-1109.
[7] Wassmann S, Laufs U, B?umer AT, el al. Inhibition of geranylation reduces angiotensin mediated free radical production in vascular smooth muscle cells:involvement of angiotensin ATI receptor expression and Racl GTPase[J]. Mol Pharmacol, 2001, 59(3): 646-654.
[8] 薛艳琴. 蒋跃绒. 氟伐他汀联合康复护理干预对心脏介入治疗患者氧化应激及再发心血管事件的影响[J]. 中国药业, 2015, 24(1): 35-37.
[9] 崔洪臣. 氧化应激与糖尿病肾病[J]. 临床内科杂志, 2015, 32(1): 65-66.
[10] Kural BV, Orem C, Uydu HA, et al. The effects of lipidlowering therapy on paraoxonase activities and their relationships with the oxidant-antioxidant system in patients with dyslipidemia[J]. Coron Artery Dis, 2004,15(5): 277-283., 百拇医药(张冬梅)
[3] Amaud C, Mach F. Pleiotropic effects of statins in atherosclerosis:role on endothelial fimction, inflammation and immunomodulation[J]. Arch Mal Coeur Vaiss, 2005, 98(6): 661-666.
[4] 丁晓洁. 不同剂量氟伐他汀对血脂正常的早期糖尿病肾病的影响[J]. 安徽医药, 2014, 18(4): 740-741.
[5] 郑美玲, 樊均明. 氧化应激对糖尿病肾病时细胞、细胞外基质及血管通透性的影响机制[J]. 中国组织工程研究与临床康复, 2007, 11(25): 4988-4991.
[6] 刘东宁, 朱新宁, 寇华炜, 等. 氟伐他汀对糖尿病大鼠心肌组织氧化应激反应的影响[J]. 宁夏医学杂志, 2010,32(12): 1107-1109.
[7] Wassmann S, Laufs U, B?umer AT, el al. Inhibition of geranylation reduces angiotensin mediated free radical production in vascular smooth muscle cells:involvement of angiotensin ATI receptor expression and Racl GTPase[J]. Mol Pharmacol, 2001, 59(3): 646-654.
[8] 薛艳琴. 蒋跃绒. 氟伐他汀联合康复护理干预对心脏介入治疗患者氧化应激及再发心血管事件的影响[J]. 中国药业, 2015, 24(1): 35-37.
[9] 崔洪臣. 氧化应激与糖尿病肾病[J]. 临床内科杂志, 2015, 32(1): 65-66.
[10] Kural BV, Orem C, Uydu HA, et al. The effects of lipidlowering therapy on paraoxonase activities and their relationships with the oxidant-antioxidant system in patients with dyslipidemia[J]. Coron Artery Dis, 2004,15(5): 277-283., 百拇医药(张冬梅)